In addition, p53C peptide fused with CPP inhibits the proliferation of cancer cells by reactivating endogenous p53, and significantly increases lifespan in animal models of terminal peritoneal carcinomatosis and bladder cancer in vivo [29-31]. The gene discussed is TP53; the disease is urinary bladder carcinoma.